[Catecholamine].
Horita
Hiroki
H
Department of Urology, Hokkaido Saiseikai Otaru Hokusei Hospital.
Sato
Yoshikazu
Y
Tsukamoto
Taiji
T
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D002395:Catecholamines / Q000502:physiology; D007172:Erectile Dysfunction / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D008297:Male; D009130:Muscle, Smooth / Q000502:physiology; D009638:Norepinephrine / Q000502:physiology*; D010413:Penis / Q000098:blood supply / Q000294:innervation*; D010646:Phentolamine / Q000627:therapeutic use; D011941:Receptors, Adrenergic / Q000502:physiology
D000317:Adrenergic alpha-Antagonists; D002395:Catecholamines; D011941:Receptors, Adrenergic; D009638:Norepinephrine; D010646:Phentolamine